Related Experiment Video
Updated: May 25, 2026

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel
Published on: October 13, 2018
Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix
Chandra Shekhar Boosani1, Yakkanti A Sudhakar
1Cell Signaling, Retinal and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research Hospital, Omaha, NE 68131, USA; ChandraShekhar.Boosani@boystown.org.
This review explores extracellular matrix-derived angioinhibitors, molecules that regulate blood vessel formation. Understanding their mechanisms offers potential therapeutic strategies for diseases like cancer and AMD.
Area of Science:
- Biochemistry
- Cell Biology
- Medical Science
Background:
- Angiogenesis, or neovascularization, is crucial for physiological and pathological processes.
- An imbalance between angioinhibitors and angioactivators underlies diseases like cancer, AMD, and diabetic retinopathy.
- Endogenous molecules derived from proteolysis exhibit angioinhibition and antitumor activities.
Purpose of the Study:
- To review extracellular matrix (ECM)-derived angioinhibitors.
- To elucidate their mechanisms of action.
- To highlight their clinical significance and therapeutic potential.
Main Methods:
- Literature review focusing on ECM-derived angioinhibitors.
- Analysis of molecular interactions with endothelial and tumor cells.
- Examination of intracellular signaling pathways regulated by these inhibitors.
Main Results:
- ECM-derived angioinhibitors bind to specific integrins on endothelial and tumor cells.
- These interactions trigger intracellular signaling pathways.
- Signaling pathways influence cell survival and apoptosis.
Conclusions:
- ECM-derived angioinhibitors represent a promising therapeutic avenue.
- Targeting these molecules may offer new treatments for angiogenesis-related diseases.
- Further research into their mechanisms can unlock clinical applications.
Related Concept Videos
Matrix Proteoglycans and Glycoproteins
Mechanism of Angiogenesis
Role of Matrix Metalloproteases in Degradation of ECM
A...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Regulation of Angiogenesis and Blood Supply
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

